| Name | Navin Viswakarma |
|---|---|
| University | University of Illinois |
| Country | USA |
| Position | Editorial board member |
Dr. Navin Viswakarma is Research Assistant Professor in Division of surgical oncology in the Department of Surgery, University of Illinois at Chicago (UIC). Dr. Viswakarma completed his PhD in Molecular Biology and Biochemistry in 2002 from the Nagpur University, India. He did his postdoctoral fellowship from the Northwestern University, Chicago (2004-2011). His research at Northwestern was focused on studying the molecular mechanisms that regulate the transcriptional activities of nuclear receptors in energy metabolism, fatty liver disease and hepatocellular carcinoma. His work produced several peer-reviewed publications that leads to funding of grants. In 2011, he joined as a Principal Research Scientist at the Institute of Life Sciences (ILS), Hyderabad, India. He also overlooked a CRO, PharmakoDyne Biosciences at ILS. Later he joined UIC where presently he is working on the pancreatic and liver cancer. His work involves translational implication of MAPK inhibitors that target novel pathway in the PDAC and breast cancer.
